These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 25465643)

  • 1. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
    Walter J; Ware LB; Matthay MA
    Lancet Respir Med; 2014 Dec; 2(12):1016-26. PubMed ID: 25465643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie S; Masterson C; Devaney J; Laffey JG
    Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cell therapies: potential and pitfalls for ARDS.
    Masterson C; Jerkic M; Curley GF; Laffey JG
    Minerva Anestesiol; 2015 Feb; 81(2):179-94. PubMed ID: 24492665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome.
    Matthay MA
    Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S54-7. PubMed ID: 25830837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value.
    Laffey JG; Matthay MA
    Am J Respir Crit Care Med; 2017 Aug; 196(3):266-273. PubMed ID: 28306336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome.
    Cárdenes N; Cáceres E; Romagnoli M; Rojas M
    Respiration; 2013; 85(4):267-78. PubMed ID: 23428562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in mesenchymal stem cell research in sepsis.
    Wannemuehler TJ; Manukyan MC; Brewster BD; Rouch J; Poynter JA; Wang Y; Meldrum DR
    J Surg Res; 2012 Mar; 173(1):113-26. PubMed ID: 22225756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.
    Johnson CL; Soeder Y; Dahlke MH
    Stem Cells Transl Med; 2017 Apr; 6(4):1141-1151. PubMed ID: 28186706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome.
    Han J; Liu Y; Liu H; Li Y
    Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
    Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
    Front Immunol; 2021; 12():738697. PubMed ID: 34659231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Orphan Receptor Tyrosine Kinase ROR2 Facilitates MSCs to Repair Lung Injury in ARDS Animal Model.
    Cai SX; Liu AR; Chen S; He HL; Chen QH; Xu JY; Pan C; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
    Cell Transplant; 2016; 25(8):1561-74. PubMed ID: 26531175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury.
    Islam D; Huang Y; Fanelli V; Delsedime L; Wu S; Khang J; Han B; Grassi A; Li M; Xu Y; Luo A; Wu J; Liu X; McKillop M; Medin J; Qiu H; Zhong N; Liu M; Laffey J; Li Y; Zhang H
    Am J Respir Crit Care Med; 2019 May; 199(10):1214-1224. PubMed ID: 30521764
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome.
    Horie S; Laffey JG
    F1000Res; 2016; 5():. PubMed ID: 27408702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome.
    Antebi B; Mohammadipoor A; Batchinsky AI; Cancio LC
    J Trauma Acute Care Surg; 2018 Jan; 84(1):183-191. PubMed ID: 29019797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overview and perspectives of mesenchymal stem cell therapy in intensive care medicine].
    Espinoza F; Aliaga F; Crawford PL
    Rev Med Chil; 2016 Feb; 144(2):222-31. PubMed ID: 27092677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats.
    Zhao F; Zhang YF; Liu YG; Zhou JJ; Li ZK; Wu CG; Qi HW
    Transplant Proc; 2008 Jun; 40(5):1700-5. PubMed ID: 18589176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.
    McIntyre LA; Moher D; Fergusson DA; Sullivan KJ; Mei SH; Lalu M; Marshall J; Mcleod M; Griffin G; Grimshaw J; Turgeon A; Avey MT; Rudnicki MA; Jazi M; Fishman J; Stewart DJ;
    PLoS One; 2016; 11(1):e0147170. PubMed ID: 26821255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.